UK medical device company Owen Mumford has signed a new three-year agreement to supply insulin pens to sanofi-aventis for global distribution.

The Autopen 24 reusable insulin pen will be used with sanofi-aventis' insulin cartridges. The combination will be supplied to over 60 countries.

The contract renews the existing business partnership between the two companies.

Adam Mumford, Sales & Marketing Director at Owen Mumford, said: "This new agreement with sanofi-aventis is a strong endorsement of the ease of use and effectiveness of Autopen 24 in assisting patients in the management of their diabetes, acknowledged by healthcare professionals and patients alike."

Oxford-based Owen Mumford is a leading UK manufacturer of medical devices for the treatment of diabetes.